I'll make a few other comments. This whole saga has led me to ask: why on earth does New Zealand have Medsafe? And some people might say, "Oh, you've got to have Medsafe." Well, let me ask the question: has Medsafe ever assessed a medicine that's been approved by the Food and Drug Administration, and by the Australians, by the British, and said, "Oh, no, no, the rest of the world's got it wrong. New Zealanders can't use it." Has that ever happened? I don't think it's ever happened. And the question is: is it necessary for New Zealand to have its whole process and rigmarole, which has brought us into this House tonight to retrospectively change legislation, in order to delay the access of New Zealanders to pharmaceuticals that were funded offshore long ago? You see, the sad fact is that, due to low productivity growth and an aversion to putting funds into medicine, we actually are usually at the back of the bus, the last in the queue, to get new pharmaceuticals. So by the time we get them, they've already been signed off by a bunch of other countries' similar authorities. And I just wonder if we shouldn't be automatically accepting their approval. It's not that humans are substantially different in New Zealand from humans in other countries—not as far as I'm aware. So, that's the first question, but it's particularly acute in the case of this particular issue. 